To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02319837
Title Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Medivation, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | SVK | POL | NLD | ITA | GBR | FRA | FIN | ESP | DNK | CAN | BRA | AUT | AUS


No variant requirements are available.